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A. ECONOMOPOULOU 1,2*, M. DOMINGUEZ 1,3, B. HELYNCK1, D. SISSOKO4,
O. WICHMANN 5, P. QUENEL 6, P. GERMONNEAU 1 AND I. QUATRESOUS1
1 Institute de Veille Sanitaire, France
2 European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease
Prevention and Control, Stockholm, Sweden
3 Training Programme in Field Epidemiology, Institut de Veille Sanitaire, France
4 Cellule Interrégionale d’Epidémiologie Réunion-Mayotte
5 Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
6 Cellule Interrégionale d’Epidémiologie Antilles-Guyane
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SUMMARY
In April 2005, an outbreak of Chikungunya fever occurred on the island of Réunion in the Indian
Ocean. During winter 2005, six patients developed meningoencephalitis and acute hepatitis due to
Chikungunya virus. Our objectives were to determine the incidence and mortality of atypical
Chikungunya viral infections and to identify risk factors for severe disease. A hospital-based
surveillance system was established to collect data on atypical Chikungunya cases. Case reports,
medical records and laboratory results were reviewed and analysed. We defined an atypical case
as one in which a patient with laboratory-confirmed Chikungunya virus infection developed
symptoms other than fever and arthralgia. We defined a severe atypical case as one which
required maintenance of at least one vital function. We recorded 610 atypical cases of
Chikungunya fever : 222 were severe cases, 65 affected patients died. Five hundred and forty-six
cases had underlying medical conditions (of which 226 suffered from cardiovascular, 147 from
neurological and 150 from respiratory disorders). Clinical features that had never been associated
with Chikungunya fever were recorded, such as bullous dermatosis, pneumonia, and diabetes
mellitus. Hypertension, and underlying respiratory or cardiological conditions were independent
risk factors for disease severity. The overall mortality rate was 10.6% and it increased with age.
This is the first time that severe cases and deaths due to Chikungunya fever have been
documented. The information presented in this article may assist clinicians in identifying the
disease, selecting the treatment strategy, and anticipating the course of illness.
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INTRODUCTION
Chikungunya fever is an arboviral disease transmitted
to humans by infected mosquitoes of the Aedes genus
[1]. Since the first isolated incident in 1952, several
outbreaks of the disease, caused by this Alphavirus,
have been documented throughout South-East Asia,
and Africa [2–5]. After an incubation period of 1–12
days, patients usually develop a sudden onset of fever,
headache and arthralgia [6]. Conjunctivitis and rash
are also common features of Chikungunya fever. The
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disease is not generally considered life-threatening,
and prior to 2005 severe clinical forms of the infection
were rarely described [7].
In April 2005 an outbreak of Chikungunya fever
first manifested itself on the French island territory of
Réunion, located in the Archipelago of Mascareignes
(South-West Indian Ocean) [7]. According to reports
from the Réunion-Mayotte Inter-Regional Epidemio-
logical Unit (IREU), as of mid-April 2006, 266 000/
785 221 (34%) inhabitants had been infected by the
virus [8]. Health-care facilities on Réunion are similar
to those of mainland France. The island is divided
into 24 counties grouped in four regions, each region
having a hospital.
In autumn 2005 during the early warm season six
patients who were hospitalized with Chikungunya
fever on Réunion developed atypical clinical features,
four of them developed meningoencephalitis and
two acute hepatitis. In response to this observation,
we established a hospital-based surveillance system
to identify the hospitalized patients who developed
clinical features of Chikungunya fever other than the
typical fever – arthralgia. The objectives of the sur-
veillance system were to describe the atypical clinical
forms of Chikungunya fever, to determine its inci-
dence and mortality and to assess risk factors for se-
vere disease and death.
MATERIALS AND METHODS
Between 1 February and 31 May 2006, epide-
miologists from the Réunion-Mayotte IREU, on a
weekly basis, contacted referring physicians from all
four hospitals on the island inquiring about newly
hospitalized Chikungunya fever cases with atypical
disease symptoms. In addition, a retrospective data
collection was conducted to identify atypical cases
that occurred between 1 April 2005 and 31 March
2006.
Chikungunya fever cases required biological con-
firmation either by serological testing (IgM-antibody
titres indicating acute or recent infection), or by
detecting the presence of Chikungunya virus
genome in any body specimen using real-time reverse
transcription–polymerase chain reaction assays
(RT–PCR). Samples of blood serum, cerebrospinal
fluid or serum from bullous lesions were tested with
an IgM-capture enzyme-linked immunosorbent assay
(ELISA) for antibodies against Chikungunya virus
and by a standard RT–PCR technique [9]. A case was
considered to be biologically confirmed if any one of
the above performed tests in any clinical specimen
were positive.
We defined as an ‘atypical case ’ of Chikungunya
fever as one in which a patient hospitalized from April
2005 onwards on Réunion, developed, apart from
fever and arthralgia, one or more other symptoms
and had laboratory evidence of acute or recent
Chikungunya virus infection. This atypical case was
defined as a ‘severe case ’ of Chikungunya fever re-
quiring the maintenance of at least one vital function.
All patients with Chikungunya infection that died
during the course of the disease were defined as severe
cases.
Case reports, medical records, and the results of
biological tests were reviewed for each Chikungunya
fever case by an epidemiologist in order to identify
patients with atypical manifestations. For each atypi-
cal case, a standard questionnaire was completed.
Signs or symptoms not mentioned in medical records
were considered as absent. In order to confirm
the findings extracted from the medical records the
treating neurologist, cardiologist, and intensive care
physician of the reanimation ward of the two main
hospitals were also contacted.
Data on underlying conditions such as hyperten-
sion, diabetes, cardiovascular and respiratory dis-
orders, cancer and alcoholism were recorded from
the patient’s medical records. Patients were classified
as having meningoencephalitis, if the cerebrospinal
fluid test was positive by PCR or IgM-capture
ELISA. A patient with diabetes mellitus and hyper-
tension who also presented neurological features was
not classified as having a neurological disorder owing
to the infection. A patient with a simultaneous infec-
tion was characterized as having a concomitant dis-
ease. Only adult patients (i.e. aged>15 years) have
been included in the present analysis. Clinical mani-
festation in children will be reported elsewhere.
Analysis of the collected data was performed using
Stata statistical software, version 8.0 (StataCorp LP,
College Station, TX, USA). Denominators that were
used to calculate proportions for the reported data
varied, based on available information. Incidence and
mortality were calculated according to the 2001
Réunion population census data [8]. A multivariate
analysis was conducted to examine the association
between age, sex, underlying health status, alcohol-
ism, diabetes, use of non-steroidal anti-inflammatory
drugs (NSAIDs) and disease severity and death in
all notified atypical cases. For this purpose, logistic
regression models were developed with stepwise
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backwards removal of non-significant variables.
Original models included gender, age and all variables
with a P value <0.2 in the bivariate analysis. A P
value <0.05 was considered statistically significant.
RESULTS
Between 1 April 2005 and 31 March 2006, a total of
878 patients with atypical Chikungunya symptoms
were investigated. Over the same period, the incidence
of atypical cases on Réunion was 112/100 000 in-
habitants. Taking into consideration the estimates
for the total number of infected people reported
previously, the proportion of atypical cases in all
Chikungunya patients was 0.3% [8]. The majority
of hospitalized atypical cases occurred in February
and March 2006; this time period coincides with the
period of the highest reporting of Chikungunya fever
cases on Réunion (Fig. 1) [9, 10].
In all atypical cases, 610 were adults, 224 were
children aged <16 years, and 44 were newborns aged
<10 days who were infected by mother-to-child
transmission. The present study presents the analysis
of exclusively adult patient data.
The median age of the cases was 70 years (range
15–95) and the sex ratio (M/F) was 0.8. In the
610 atypical cases, 222 (36%) were severe cases.
Eighty-four (14%) were admitted to an intensive care
unit and 65 of the severe cases (29%) died, accounting
for an overall case-fatality rate of 10.7%.
The incidence of atypical cases, severe cases, and
the mortality rate increased with age. Therefore, the
incidence of the disease was more than 30 times higher
in patients aged o65 years compared to those aged
<45 years (Table 1).
Clinical features and underlying health status
Of the 610 atypical cases, 546 (89%) had underlying
medical conditions, 479 (78%) were on medication
prior to hospitalization, 84 (14%) used NSAIDs
and 88 (14%) were alcohol abusers. The recorded
underlying medical conditions are summarized in
Table 2.
Almost all patients during physical examination
on admission presented fever (90%). Other recorded
symptoms included malaise (45%), altered mental
status (24%), diarrhoea or vomiting (18%), dyspnoea
(15%), myalgia (13%), chest pain (4%), gastrointes-
tinal bleeding (4%), and haematuria (1%).
Atypical clinical features recorded during hospital-
ization are summarized in Table 3. In 120 patients
hospitalized with pre-renal acute renal failure, 41
(34%) presented an exacerbation of a pre-existing
renal disorder. Of these 36 had chronic renal failure,
two had a nephropathy and three had a history of
renal transplantation. In 102 patients hospitalized
with pneumonia, 17 had a history of chronic
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Fig. 1. Number of atypical and severe Chikungunya cases (n=610) and total number of notified Chikungunya cases by
calendar week, Réunion, April 2005 to April 2006. * Data from total weekly notified cases have been adapted from Martin
et al. [9].
536 A. Economopoulou and others
A rash which was described as an erythematous
macular, papular or morbiliform eruption was re-
ported in 104 (17%) patients and affected one or more
of the following areas : neck, trunk, arms and legs.
Four per cent of the cases presented itching and
desquamation. Seventeen cases presented bullous
dermatosis, of which 3% required intensive care unit
admission. For one case a hyperpigmentation of the
nose was described.
A total of 131 of the atypical cases presented
glycaemic imbalance, 27 (20%) of them were diag-
nosed with diabetes mellitus for the first time.
Seventy-three of the atypical cases were observed
to have a greater than threefold increase of liver en-
zymes. However, information on liver enzymes was
only available for 64% of the cases.
Of the 226 patients with atypical Chikungunya fe-
ver presenting cardiovascular disease, 110 (49%) had
an underlying cardiac condition, 137 (61%) had hy-
pertension, and 66 of these (48%) also had diabetes
mellitus. Of the 84 cases with heart failure, 29 (35%)
had an underlying cardiomyopathy, 10 (12%) cor-
onary artery disease, six (7%) valvular disease, four
(5%) a history of myocardial infarction and one of
arrhythmias. Of the 44 cases with arrhythmias, seven
had arrhythmias reported as a medical underlying
condition, six cardiopathy, two valvulopathy, and
one heart failure. Of the 35 cases with myocarditis
or pericarditis, seven had a underlying cardiopathy,
two arrhythmias, and two had a history of myocardial
infarction. Of the 25 cases diagnosed with angina
pectoris, 15 (60%) had a history of coronary artery
disease. Four cases presented acute myocardial
infarction; of which two had a history of coronary
artery disease.
Of 147 cases with neurological disorders, 25 (17%)
had underlying neurological conditions, while 71
(48%) also had a diagnosis of hypertension, and 36
(24%) of diabetes mellitus. Of the 69 cases with en-
cephalitis, 12 (17%) had underlying neurological
conditions : five (7%) had suffered a stroke and five
(7%) had a history of epilepsy. Of these 34 (49%) had
a diagnosis of hypertension. Of the 15 cases with
meningoencephalitis, one had history of cysticercosis,
one of hydrocephalus, one of myasthenia gravis and
eight a diagnosis of hypertension. Eight (8%) out of
12 cases who developed seizures were previously
healthy.
Disease severity and prognosis
The univariate analysis revealed that atypical cases
aged 40–60 years were 2.5 times more likely to de-
velop severe disease than those aged <40 years [95%
confidence interval (CI), 1.13–5.48). Atypical cases
aged o60 years were 1.6 times more likely to develop
severe disease than those aged <40 years (95%
Table 2. Underlying medical conditions of 610
atypical adult Chikungunya patients (multiple
entries possible)
Underlying medical conditions Number (%)
Hypertension 329 (54)
Diabetes mellitus 242 (39)
Cardiovascular diseases 200 (32)
Neurological disorders 142 (23)
Chronic pulmonary diseases 99 (16)
Alcohol abuse 88 (14)
Kidney diseases 76 (12)
Cancer 22 (4)
Allergy 22 (4)
Concomitant diseases 22 (4)
Total 546 (89)
Table 1. Age group-specific frequency and incidence (per 100 000 inhabitants) of notified atypical












15–24 136 781 21 (15) 6 (4) 3 (2) 1 (0.7)
25–44 232 657 46 (20) 14 (6) 8 (3) 4 (2)
45–64 149 291 173 (116) 57 (38) 38 (26) 19 (13)
o65 58 851 370 (629) 145 (246) 35 (60) 41 (69)
Total 577 580 610 (106) 222 (38) 84 (15) 65 (11)
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CI 1.08–2.27). In multivariate analysis, underlying
respiratory diseases, the use of NSAIDs prior to hos-
pitalization, hypertension and underlying cardiac
disorders were independently associated with disease
severity (Table 4).
Five out of 65 (8%) reported death incidents
occurred in people who were healthy prior to hospi-
talization. Of the deceased, two developed multiple
organ failure syndrome, one meningoencephalitis,
one fulminant hepatitis, and one heart failure. Causes
of death are summarized in Table 5.
Age o85 years [relative risk (RR) 3.49, 95% CI
1.5–7.8] as well as alcohol abuse (RR 11.38, 95% CI
4.88–26.53) were associated with increased mortality.
DISCUSSION
Chikungunya fever is characterized as a mild febrile
disease [1]. The main clinical symptoms mentioned
by Robinson et al. in his original report were fever,
incapacitating arthralgia, myalgia, headache, and
diffuse maculopapular rash [2]. Other clinical symp-
toms such as diarrhoea, vomiting, persistent arthral-
gia, and on rare occasions bleeding, have also been
described, during outbreaks or in cohorts of travellers
[6, 11–13]. Only a few case reports have been pub-
lished suggesting that Chikungunya fever can be ex-
ceptionally associated with hepatitis, meningitis,
encephalitis [14, 15], myocarditis and arrhythmias
[16, 17].
This report describes the conclusions of an en-
hanced hospital-based surveillance system for atypi-
cal Chikungunya fever, implemented during the large
Chikungunya fever outbreak on Réunion during
2005–2006. Atypical cases (n=610) of Chikungunya
fever were reported, 222 were severe cases, of which
65 died. Of the 610 atypical cases, 546 (89%) had
underlying medical conditions, 84 had taken NSAIDs
and 88 (14%) were alcohol abusers. In addition,
the disease was associated with the presence of
several underlying medical conditions, with 90% of
the affected cases suffering from underlying diseases.
Suprisingly, cardiovascular disorders such as arrhyth-
mias, myocarditis, pericarditis, myocardial infarction
and neurological disorders including encephalitis
and meningoencephalitis, occurred in previously
healthy cases. Respiratory or cardiovascular under-
lying medical conditions and hypertension were
associated with increased risk of developing severe
illness. On the contrary, diabetes mellitus, despite be-
ing commonly reported as an underlying condition,
was not found to increase the risk of severe disease
or death. Our study also reveals that the risk of
severe Chikungunya fever increased substantially in
patients who used NSAIDs prior to hospitalization.
This might reflect either a more severe form of the
disease or a late admission to hospital. The role of
specific NSAIDs (aspirin or acetaminophen) could
not be determined, as this information had not been
recorded in the medical records.
This study identified a substantial number of severe
manifestations and deaths due to Chikungunya fever.
The reasons for these severe manifestations are un-
clear. It is possible that the large number of severe
cases observed simply reflect the immense size of the
outbreak. Alternatively, the fact that the outbreak





Cardiovascular disorders 226 (37)
Heart failure 84 (13)
Arrhythmias 44 (7)
Myocarditis/pericarditis 35 (6)
Blood pressure instability 34 (6)
Coronary artery disease 25 (4)
Acute myocardial infarction 4 (1)




Epileptic seizures 12 (2)
Syndrome of meningeal irritation 8 (1)
Hyperaesthesia 8 (1)




Pre-renal failure 120 (20)
Pneumonia 102 (17)
Skin affections 104 (17)
Respiratory failure 48 (8)
Exacerbation of chronic renal
failure
41 (7)
Hepatic insufficiency 22 (4)
Bullous dermatosis 17 (3)






Subacute hepatitis 5 (1)
Categories shown are not mutually exclusive, since some
cases presented more than one features.
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occurred on an island with European health stan-
dards may have increased the chance of identifying
and documenting such events [1]. On the other hand,
the spread of Chikungunya virus during the outbreak
on Réunion was found to have novel molecular fea-
tures, which may have led to its increased virulence
[18, 19].
During the 2005 outbreak, the incidence of atypical
infections on Réunion was 0.3% [8]. Although
the overall proportion of atypical cases was low,
the mortality in these cases was surprisingly high.
Mortality attributed to Chikungunya fever has never
been previously reported [1]. A study on crude death
rates on Réunion during the outbreak supports
our findings by showing 260 excess deaths between
January and April 2006 [20]. Most of the deaths in our
study occurred in cases with underlying medical con-
ditions, but five deaths occurred in previously healthy
cases. Mortality rate was clearly increasing with age.
In atypical cases, very old age was also an indepen-
dent risk factor for increased mortality rate. However,
deaths were reported even in young or middle-aged
persons. Eighty-four of the 222 severe cases were ad-
mitted to an intensive care unit. However, a large
number of severe cases were only treated in standard
wards, due to the limited admission capacity of in-
tensive care units during the epidemic peak.
A limitation of the present study was that we only
collected data from atypical Chikungunya patients
through our surveillance system. For this reason, it
was not possible to look for risk factors of atypical
disease. The dramatically increasing incidence of age-
specific atypical disease could reflect the higher oc-
curence of underlying diseases in older ages, but could
also be the result of the direct virulence of the virus.
Borgherini et al. demonstrated the factors associated
with hospitalization for Chikungunya fever : older
age, diabetes and underlying heart disease [6]. Since
Table 4. Relative risks of severity and death associated with underlying
conditions and risk factors in 610 patients with atypical Chikungunya
virus infection (results of multiple regression analysis)








Outcome: severe disease (n=222)
Underlying respiratory
disease
27 10 3.1 2.0–4.9
Use of NSAIDs prior
hospitalization
17 12 1.8 1.1–3.0
Hypertension 63 49 1.7 1.2–2.4
Underlying cardiac
disease
43 29 1.6 1.1–2.3
Outcome: death (n=65)
Alcohol abuse 37 6 1.4 4.9–26.5
Age >85 yr 22 12 3.5 1.6–7.8
NSAIDs, Non-steroidal anti-inflammatory drugs ; RR, relative risk; CI, confidence
interval.
Table 5. Causes of deaths recorded in 65 patient
with severe atypical Chikungunya fever
Causes of death Number (%)
Heart failure 15 (23)
Multiple organ failure syndrome 11 (18)
Toxic hepatitis 7 (11)
Encephalitis or meningoencephalitis 6 (9)
Bullous dermatosis 6 (9)
Myocarditis/pericarditis 5 (8)
Respiratory failure 5 (8)
Renal failure 3 (5)
Pneumonia 2 (3)
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we used a hospital-based surveillance system, atypical
but mild Chikungunya fever infection might not have
been detected, suggesting that the incidence of atypi-
cal infection may have been underestimated in the
present study.
During this outbreak, new clinical forms of
Chikungunya fever were identified such as bullous
dermatosis, pneumonia, and diabetes mellitus. To
our knowledge, these Chikungunya fever-associated
features have never been previously reported. The re-
sulting disease varied from mild (with fever, gastro-
intestinal disorders, maculopapular rush) to severe
(Guillain–Barré, meningoencephalitis, heart failure,
pneumonia). The underlying physiopathology for
some of these disorders remains unclear. However,
clinical features of atypical cases could be grouped
mainly into three major categories : exacerbation of
underlying medical conditions, deterioration of a
previously unrecognized disorder, or exaggerated di-
rect response to viral infection. The information pre-
sented in this paper may assist clinicians in identifying
the disease, selecting the treatment strategy, and an-
ticipating the course of illness. Today’s frequent in-
ternational travel from one continent to another
may facilitate the introduction (spread) of the virus
in areas where the vector is present. This has been
recently experienced in Italy, where a traveller who
returned from India was identified as the most likely
source of an outbreak of Chikungunya fever which
affected >200 people [21]. Clinicians in developed
countries should be aware of this possibility and
should consider the risk of a more severe disease in the
elderly.
The existence of a developed medico-technical
background on Réunion, the vigilant epidemiological
investigation and the systematic performance of
serological testing of suspected Chikungunya patients
enhanced our knowledge of the unusual clinical
characteristics of Chikungunya fever and gave us a
better understanding of the epidemic which has led
to appropriate prevention policies. The knowledge
of the severity of the disease may facilitate its future
management and strengthen the strategy of miti-
gation.
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